Skip to main content
. 2013 Jun 30;29(3):106–114. doi: 10.3393/ac.2013.29.3.106

Fig. 4.

Fig. 4

Disease-free survival curves for individualized optimal cutoff carcinoembryonic antigen (CEA) values. (A) Disease-free survival and optimal CEA cutoff value in each TNM stage. (B) Disease-free survival and optimal CEA cutoff value in each N stage.